Literature DB >> 9420792

Comparison of imaging properties of technetium 99m Q12 and technetium 99m Q3 in humans.

M C Gerson1, J Lukes, E Deutsch, D Biniakiewicz, L C Washburn, R A Walsh.   

Abstract

BACKGROUND: This study was a direct comparison of the imaging characteristics of 99mTc-labeled Q12 (99mTc-Q12) and 99mTc-labeled Q3 (99mTc-Q3) in the same patients. METHODS AND
RESULTS: In 10 patients with known angiographic coronary artery anatomy, 99mTc-Q12 and 99mTc-Q3 myocardial imaging were performed. Tomographic myocardial imaging was started 15 minutes after tracer injection at rest and with treadmill exercise. Ratios of heart-to-lung and heart-to-liver activity were calculated from the anterior plane projections of the tomograms at 20 minutes after tracer injection. The presence or absence of angiographic coronary artery disease was correctly determined from 99mTc-Q12 images in 10 of 10 patients with 99mTc-Q12 and in 9 of 10 patients with 99mTc-Q3. The presence or absence of a greater than 50% stenosis in an individual coronary vessel was correctly predicted for 26 of 30 vessels with 99mTc-Q12 (87%) and in 27 of 30 vessels with 99mTc-Q3 (90%, p = NS vs 99mTc-Q12). Mean heart-to-lung activity ratio at rest was 1.50 for 99mTc-Q12 and 1.93 for 99mTc-Q3 (p < 0.01). Mean heart-to-liver activity ratio at rest for 99mTc-Q12 was 0.78 versus 0.54 for 99mTc-Q3 (p < 0.0001).
CONCLUSIONS: In 10 patients with chest pain and angiographically defined coronary anatomy, 99mTc-Q12 and 99mTc-Q3 provided similar detection of coronary artery stenoses. At 20 minutes after tracer injection, heart-to-liver activity ratios were more favorable for 99mTc-Q12 than for 99mTc-Q3, but 99mTc-Q3 resulted in a more favorable ratio of heart-to-lung activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420792     DOI: 10.1016/s1071-3581(05)80059-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  20 in total

1.  Myocardial imaging with Tc-99m teboroxime: technique and initial results.

Authors:  A S Iskandrian; J Heo; T Nguyen; J Mercuro
Journal:  Am Heart J       Date:  1991-03       Impact factor: 4.749

2.  Comparison of technetium 99m Q12 and thallium 201 for detection of angiographically documented coronary artery disease in humans.

Authors:  M C Gerson; J Lukes; E Deutsch; D Biniakiewicz; R C Rohe; L C Washburn; C Fortman; R A Walsh
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

3.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

4.  Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humans.

Authors:  E Deutsch; J L Vanderheyden; P Gerundini; K Libson; W Hirth; F Colombo; L Zecca; A Savi; F Fazio
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

5.  Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; R Essiambre; D C Phaneuf; J Léveillé
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

6.  Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.

Authors:  C Rossetti; G Vanoli; G Paganelli; M Kwiatkowski; F Zito; F Colombo; C Bonino; A Carpinelli; R Casati; K Deutsch
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

7.  Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs.

Authors:  M C Gerson; R W Millard; A J McGoron; M Gabel; L C Washburn; D Biniakiewicz; R C Elder; E Deutsch; R A Walsh
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

8.  Kinetic properties of 99mTc-Q12 in canine myocardium.

Authors:  M C Gerson; R W Millard; N J Roszell; A J McGoron; M Gabel; L C Washburn; D Biniakiewicz; D Blankenship; W H Mallin; R C Elder
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

9.  Thallium-201 stress-redistribution myocardial rotational tomography: development of criteria for visual interpretation.

Authors:  F M Prigent; J Maddahi; E Garcia; J Friedman; K Van Train; J Bietendorf; H J Swan; D S Berman
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more
  1 in total

1.  Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function.

Authors:  A Cuocolo; G Rubini; W Acampa; E Nicolai; L Florimonte; G DiGiovine; A D'Addabbo; M Salvatore
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.